PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Porfimer→

Porfimer PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
87806-31-3
Molecular formula
Not available
Molecular weight
Not available
Drug class
Porphyrin-based photosensitiserphotodynamic therapy antineoplastic agent
Mechanism of action
After intravenous administration, porfimer accumulates in selected tissues. Exposure to appropriate wavelength light generates reactive oxygen species, causing local cellular injury, vascular damage and tumour necrosis.
Indications / reported uses
  • Photodynamic therapy for microinvasive endobronchial non-small-cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated
  • Palliation of symptoms and obstruction in patients with completely or partially obstructing endobronchial NSCLC; treatment requires light activation and careful protection from photosensitivity

Sources: US DailyMed — PHOTOFRIN (porfimer sodium) · US FDA prescribing information · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Porfimer PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Porfimer Permitted Daily Exposure (PDE) report (the Porfimer PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Porfimer Occupational Exposure Limit (OEL) report (the Porfimer OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.